Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Literature
1.
National Institutes of Health NH, Lung, and Blood Institute. Morbidity and mortality: 2012 chart book on cardiovascular, lung, and blood diseases. Bethesda, MD: National Heart, Lung, and Blood Institute: 2012.
2.
Daly CA, De Stavola B, Sendon JL et al (2006) Predicting prognosis in stable angina: results from the Euro heart survey of stable angina: prospective observational study. BMJ 332:262–267CrossRef
3.
Arnold SV, Jang JS, Tang F et al (2015) Prediction of residual angina after percutaneous coronary intervention. Eur Heart J 1:23–30
4.
Perk J, De Backer G, Gohlke H et al (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J 33:1635–1701CrossRef
5.
Commissione ANMCO/GICR-IACPR/GISE, Greco C, Bovenzi FM, Berti S et al (2014) Documento ANMCO/GICR-IACPR/GISE—L’organizzazione dell’assistenza nella fase post-acuta delle sindromi coronariche. G Ital Cardiol 15(Suppl 1):3S–27S
6.
Cannon CP, Harrington RA, James S et al (2010) Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndrome (PLATO): a ranomised double-blind study. Lancet 375:283–293CrossRef
7.
Yusuf S, Wittes J, Friedman L (1988) Overview of results of randomized clinical trials in heart disease. Treatments following myocardial infarction. JAMA 260:2088–2093CrossRef
8.
Jerling M (2006) Clinical pharmacokinetics of ranolazine. Clin Pharmacokinet 45:469–491CrossRef
9.
Timmis AD, Chaitman BR, Crager M (2006) Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes. Eur Heart J 27:42–48CrossRef
10.
Morrow DA, Scirica BM, Chaitman BR et al (2009) Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial. Circulation 119:2032–2039CrossRef
11.
12.
Safdar B, D’Onofrio G, Dziura J et al (2017) Ranolazine and microvascular angina by PET in the Emergency Department: results from a pilot randomized controlled trial. Clin Ther 39:55–63CrossRef
13.
Califf RM, Mark DB, Harrell FE Jr et al (1988) Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. J Am Coll Cardiol 11:20–26CrossRef
Metadata
Title
Management of chronic ischemic heart disease into internal medicine and geriatric departments in Italy
Authors
Francesco Perticone
Andrea Fontanella
Nicola Ferrara
Alberto Ferrari
Publication date
01-01-2020
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 1/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02197-y

Other articles of this Issue 1/2020

Internal and Emergency Medicine 1/2020 Go to the issue

IM - REVIEW

Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes

IM - ORIGINAL

Effect of corticosteroids on myocardial injury among patients hospitalized for community-acquired pneumonia: rationale and study design. The colosseum trial

CE - LETTER TO THE EDITOR

Beyond Laennec: Aurelio Bianchi and the phonendoscope

IM - COMMENTARY

Percutaneous treatment of mitral regurgitation: looking for a final model

IM - COMMENTARY

Managing atrial fibrillation: the need for an individualized approach even in the emergency department

OBITUARY

Obituary: Giuseppe Licata (1943–2019)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits